These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

242 related items for PubMed ID: 9408014

  • 41. Comparison between von Willebrand factor (VWF) and VWF antigen II in normal individuals and patients with von Willebrand disease.
    de Romeuf C, Mazurier C.
    Thromb Haemost; 1998 Jul; 80(1):37-41. PubMed ID: 9684782
    [Abstract] [Full Text] [Related]

  • 42.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 43.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 44. Endothelial haemostatic factors may be associated with mortality in patients on long-term anticoagulant treatment.
    Brännström M, Jansson JH, Boman K, Nilsson TK.
    Thromb Haemost; 1995 Aug; 74(2):612-5. PubMed ID: 8584993
    [Abstract] [Full Text] [Related]

  • 45.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 46.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 47.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 48. Endothelial activation, dysfunction, and damage in congestive heart failure and the relation to brain natriuretic peptide and outcomes.
    Chong AY, Freestone B, Patel J, Lim HS, Hughes E, Blann AD, Lip GY.
    Am J Cardiol; 2006 Mar 01; 97(5):671-5. PubMed ID: 16490435
    [Abstract] [Full Text] [Related]

  • 49.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 50.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 51. Mild hyperhomocysteinemia and hemostatic factors in patients with arterial vascular diseases.
    Freyburger G, Labrouche S, Sassoust G, Rouanet F, Javorschi S, Parrot F.
    Thromb Haemost; 1997 Mar 01; 77(3):466-71. PubMed ID: 9065995
    [Abstract] [Full Text] [Related]

  • 52.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 53.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 54. von Willebrand factor as a marker of endothelial cell activation following BMT.
    Collins PW, Gutteridge CN, O'Driscoll A, Blair S, Jones L, Aitchison R, Kelsey SM, Chopra R, Goldstone A, Newland AC.
    Bone Marrow Transplant; 1992 Dec 01; 10(6):499-506. PubMed ID: 1490199
    [Abstract] [Full Text] [Related]

  • 55. [Activation of endothelium-dependent hemostatic factors following bone marrow transplantation].
    Tsakiris DA, Marbet GA, Tichelli A, Gratwohl A, Speck B.
    Schweiz Med Wochenschr; 1995 Mar 04; 125(9):416-9. PubMed ID: 7892569
    [Abstract] [Full Text] [Related]

  • 56.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 57.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 58.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 59. Changes in the levels of endothelium-derived coagulation parameters in nonalcoholic fatty liver disease.
    Bilgir O, Bilgir F, Bozkaya G, Calan M.
    Blood Coagul Fibrinolysis; 2014 Mar 04; 25(2):151-5. PubMed ID: 24317388
    [Abstract] [Full Text] [Related]

  • 60.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 13.